+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Fragment-Based Drug Discovery Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • PDF Icon

    Report

  • 117 Pages
  • July 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5614477
Description Jump to:
The fragment-based drug discovery (FBDD) market is expected to experience a CAGR of 11.7% during the forecast period of 2023 to 2031, driven by several key drivers that have revolutionized drug development methodologies. FBDD is a robust and innovative approach that has gained prominence in the pharmaceutical industry due to its ability to identify highly potent lead compounds with lower molecular weight, ultimately simplifying the chemical synthesis and optimization process. This analysis provides a brief overview of the fragment-based drug discovery market and delves into the three main drivers, along with an exploration of one significant restraint impacting the market. Additionally, we will examine the market's segmentation by component and end-user, highlighting segments with the highest revenue and Compound Annual Growth Rate (CAGR), as well as geographic trends, regions with the highest CAGR, and regions with the highest revenue percentage. Furthermore, we will explore the competitive landscape, including top players and key strategies for the forecast period from 2023 to 2031.

Enhanced Drug Discovery Efficiency

The remarkable efficiency of fragment-based drug discovery is a key driver behind its adoption in the pharmaceutical industry. Traditional high-throughput screening methods often involve screening large compound libraries, which can be time-consuming and resource-intensive. In contrast, FBDD focuses on the initial screening of small chemical fragments, which simplifies the process by targeting critical interactions with the drug target. This targeted approach significantly increases the probability of identifying lead compounds with high affinity, potency, and specificity, thus accelerating the drug discovery timeline. FBDD also enables the exploration of chemical space more effectively by screening smaller fragments, allowing for a broader coverage of potential lead structures. The efficient identification of promising lead compounds early in the drug development process reduces the risk of costly failures at later stages, enhancing overall drug discovery efficiency.

Rising Demand for Targeted Therapies

The increasing demand for targeted therapies has been a significant driver propelling the adoption of fragment-based drug discovery. Targeted therapies focus on specific molecular targets involved in disease processes, which offers the potential for more precise and personalized treatment options. FBDD allows researchers to design drugs that specifically interact with the desired target, minimizing off-target effects and reducing the risk of adverse reactions. As personalized medicine gains traction, fragment-based drug discovery provides a valuable tool to identify lead compounds tailored to individual patient needs. This demand for targeted therapies has also been driven by the growing prevalence of complex diseases, such as cancer and autoimmune disorders, which require treatments that can selectively act on specific disease pathways.

Advancements in Structural Biology and Computational Techniques

Advancements in structural biology and computational techniques have been instrumental in driving the success of fragment-based drug discovery. Structural biology techniques, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, provide detailed insights into the three-dimensional structures of drug targets. This valuable information aids in the identification of potential binding sites for small fragments, guiding the design of more effective lead compounds. Computational techniques, including molecular docking and virtual screening, complement experimental methods by predicting the binding affinities and interactions between fragments and target proteins. These techniques significantly accelerate the screening process, allowing researchers to efficiently explore a vast chemical space and identify promising fragment hits.

Limited Fragment Chemical Diversity

Despite its many advantages, the fragment-based drug discovery market faces a significant restraint related to the limited chemical diversity of fragments. FBDD relies on screening relatively small fragments, and this can restrict the variety of chemical functionalities represented in the initial fragment libraries. As a result, certain chemical interactions and binding sites may not be adequately explored during the early stages of the drug discovery process. Limited chemical diversity can potentially lead to overlooking essential chemical interactions or target classes that could result in the identification of highly potent lead compounds. Addressing this restraint requires continuous efforts to expand and diversify fragment libraries, either through internal research or collaborations with other research institutions.

Market Segmentation by Component

In 2022, Fragment Optimization held a prominent position in the FBDD market. The elaboration and optimization of initial fragment hits to develop lead compounds involve extensive research and expertise. Pharmaceutical companies are willing to invest significantly in Fragment Optimization services as it is a critical stage in the drug discovery process. Moreover, the growing understanding of structure-activity relationships and advancements in medicinal chemistry techniques contribute to the higher revenue potential of Fragment Optimization services.

Market Segmentation by End-User

In 2022, Pharmaceutical companies represent the highest revenue-generating end-user segment in the fragment-based drug discovery market. These companies actively utilize FBDD to identify potential lead compounds for various therapeutic targets.Pharmaceutical companies often have extensive drug discovery pipelines and research budgets, allowing them to invest in innovative approaches like FBDD. As the need for novel drug candidates continues to rise, pharmaceutical companies leverage FBDD's efficiency and ability to identify highly potent lead compounds, driving the segment's significant revenue share.

Geographic Segment

As of 2022, North America led the market in terms of revenue, driven by its advanced healthcare infrastructure, well-established pharmaceutical industry, and significant research and development investments. However, the Asia Pacific region is expected to witness the highest CAGR during the forecast period from 2023 to 2031. The Asia Pacific region's projected high CAGR can be attributed to several factors, including the increasing prevalence of chronic diseases, the growing focus on drug development, and the rising investments in research and development activities. Additionally, the region's vast patient population offers substantial opportunities for targeted therapies, driving the demand for fragment-based drug discovery services.

Competitive Trends and Key Strategies

The fragment-based drug discovery market is competitive, with key players vying for market share through strategic initiatives. Some of the top players in the market include Pfizer Inc., Novartis AG, and Johnson & Johnson, Alveus Pharmaceuticals Pvt. Ltd., Astex Pharmaceuticals, Charles River Laboratories International, Inc., Beactica AB, Emerald BioStructures, Inc., Crown Bioscience, Inc., Evotec AG, Proteros Fragments GmbH, Kinetic Discovery Limited, Sprint Bioscience, Sygnature Discovery and Structure Based Design, Inc. And Other Notable Players. These companies employ various strategies to strengthen their market position and gain a competitive edge in the industry. Many key players engage in collaborations and partnerships with academic institutions, research organizations, and other pharmaceutical companies to access novel technologies, expand their research capabilities, and share expertise. Collaborations allow companies to combine resources and expertise, facilitating the efficient identification of lead compounds.Leading players continuously invest in research and development activities to expand their drug discovery pipelines and explore innovative therapeutic targets. The commitment to ongoing research enables these companies to stay at the forefront of FBDD advancements and identify new opportunities for drug development.To maintain a strong market presence, top players often focus on expanding their product portfolios by introducing novel fragment libraries, specialized services, and integrated drug discovery solutions. The diversification of offerings caters to the specific needs of various pharmaceutical and biotechnology companies.Key players also emphasize geographical expansion to tap into emerging markets with a high demand for drug discovery services. Expanding their presence in regions with favorable regulatory environments and growing research and development activities opens up new growth opportunities.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofFragment-Based Drug Discovery market are as follows:
Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Fragment-Based Drug Discovery market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Component
  • Fragment Screening
  • Biophysical Techniques
 4 NMR Spectroscopy
 4 Differential Scanning Fluorimetry (DSF) Assay
 4 Fluorescence Polarization
 4 Isothermal Titration Calorimetry
 4 X-ray Crystallography
 4 Surface Plasmon Resonance (SPR)
 4 Bilayer Interferometry
 4 Mass Spectrometry (MS)
 4 Capillary Electrophoresis
 4 Weak Affinity Chromatography (WAC - HPLC-UV/MS)
 4 Other assays (biochemical)
  • Non-biophysical Techniques
  • Fragment Optimization
Application
  • Oncology
  • Central Nervous System (CNS) Disorders
  • Infectious Diseases
  • Cardiovascular Diseases
  • Metabolic Disorders
  • Inflammation & Autoimmune Diseases
End-User
  • Academic & Research Institutions
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)

Region Segment (2021 - 2031; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Fragment-Based Drug Discovery market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Fragment-Based Drug Discovery market?
  • Which is the largest regional market for Fragment-Based Drug Discovery market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Fragment-Based Drug Discovery market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Fragment-Based Drug Discovery market worldwide?

This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Fragment-Based Drug Discovery Market
2.2. Global Fragment-Based Drug Discovery Market, By Component, 2022 (US$ Million)
2.3. Global Fragment-Based Drug Discovery Market, By Application, 2022 (US$ Million)
2.4. Global Fragment-Based Drug Discovery Market, By End-User, 2022 (US$ Million)
2.5. Global Fragment-Based Drug Discovery Market, By Geography, 2022 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2022
3. Fragment-Based Drug Discovery Market: Competitive Analysis
3.1. Market Positioning of Key Fragment-Based Drug Discovery Market Vendors
3.2. Strategies Adopted by Fragment-Based Drug Discovery Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Fragment-Based Drug Discovery Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Fragment-Based Drug Discovery Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Fragment Screening
5.3.1.1. Biophysical Techniques
5.3.1.1.1. NMR Spectroscopy
5.3.1.1.2. Differential Scanning Fluorimetry (DSF) Assay
5.3.1.1.3. Fluorescence Polarization
5.3.1.1.4. Isothermal Titration Calorimetry
5.3.1.1.5. X-ray Crystallography
5.3.1.1.6. Surface Plasmon Resonance (SPR)
5.3.1.1.7. Bilayer Interferometry
5.3.1.1.8. Mass Spectrometry (MS)
5.3.1.1.9. Capillary Electrophoresis
5.3.1.1.10. Weak Affinity Chromatography (WAC - HPLC-UV/MS)
5.3.1.1.11. Other assays (biochemical)
5.3.1.2. Non-biophysical Techniques
5.3.2. Fragment Optimization
6. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Oncology
6.3.2. Central Nervous System (CNS) Disorders
6.3.3. Infectious Diseases
6.3.4. Cardiovascular Diseases
6.3.5. Metabolic Disorders
6.3.6. Inflammation & Autoimmune Diseases
7. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Academic & Research Institutions
7.3.2. Pharmaceutical & Biotechnology Companies
7.3.3. Contract Research Organizations (CROs)
8. North America Fragment-Based Drug Discovery Market, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
8.3. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
8.4. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
8.5.Fragment-Based Drug Discovery Market: By Region, 2021-2031, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
8.5.1.1.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
8.5.1.1.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
8.5.1.2.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
8.5.1.2.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
8.5.1.3.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
8.5.1.3.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
9. UK and European Union Fragment-Based Drug Discovery Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
9.3. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
9.4. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
9.5.Fragment-Based Drug Discovery Market: By Region, 2021-2031, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
9.5.1.1.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
9.5.1.1.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
9.5.1.2.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
9.5.1.2.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
9.5.1.3.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
9.5.1.3.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
9.5.1.4.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
9.5.1.4.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
9.5.1.5. France
9.5.1.5.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
9.5.1.5.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
9.5.1.5.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
9.5.1.6.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
9.5.1.6.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
10. Asia Pacific Fragment-Based Drug Discovery Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
10.3. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
10.4. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
10.5.Fragment-Based Drug Discovery Market: By Region, 2021-2031, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
10.5.1.1.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
10.5.1.1.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
10.5.1.2.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
10.5.1.2.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
10.5.1.3. India
10.5.1.3.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
10.5.1.3.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
10.5.1.3.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
10.5.1.4.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
10.5.1.4.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
10.5.1.5.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
10.5.1.5.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
10.5.1.6.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
10.5.1.6.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
11. Latin America Fragment-Based Drug Discovery Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
11.3. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
11.4. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
11.5.Fragment-Based Drug Discovery Market: By Region, 2021-2031, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
11.5.1.1.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
11.5.1.1.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
11.5.1.2.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
11.5.1.2.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
11.5.1.3.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
11.5.1.3.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
12. Middle East and Africa Fragment-Based Drug Discovery Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
12.3. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
12.4. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
12.5.Fragment-Based Drug Discovery Market: By Region, 2021-2031, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
12.5.1.1.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
12.5.1.1.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
12.5.1.2.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
12.5.1.2.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Fragment-Based Drug Discovery Market: By Component, 2021-2031, USD (Million)
12.5.1.3.2. Fragment-Based Drug Discovery Market: By Application, 2021-2031, USD (Million)
12.5.1.3.3. Fragment-Based Drug Discovery Market: By End-User, 2021-2031, USD (Million)
13. Company Profile
13.1. Pfizer Inc.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Novartis AG
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Johnson & Johnson
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Alveus Pharmaceuticals Pvt. Ltd.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Astex Pharmaceuticals
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Charles River Laboratories International, Inc.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Beactica AB
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Emerald BioStructures, Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Crown Bioscience, Inc.
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Evotec AG
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Proteros Fragments GmbH
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Kinetic Discovery Limited
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. Sprint Bioscience
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. Sygnature Discovery
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives
13.15. Structure Based Design, Inc
13.15.1. Company Overview
13.15.2. Financial Performance
13.15.3. Product Portfolio
13.15.4. Strategic Initiatives
13.16. Other Notable Players
13.16.1. Company Overview
13.16.2. Financial Performance
13.16.3. Product Portfolio
13.16.4. Strategic Initiatives
List of Figures
Figure 1 Global Fragment-Based Drug Discovery Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Fragment-Based Drug Discovery Market: Quality Assurance
Figure 5 Global Fragment-Based Drug Discovery Market, By Component, 2022
Figure 6 Global Fragment-Based Drug Discovery Market, By Application, 2022
Figure 7 Global Fragment-Based Drug Discovery Market, By End-User, 2022
Figure 8 Global Fragment-Based Drug Discovery Market, By Geography, 2022
Figure 9 Market Geographical Opportunity Matrix - Global Fragment-Based Drug Discovery Market, 2022
Figure 10 Market Positioning of Key Fragment-Based Drug Discovery Market Players, 2022
Figure 11 Global Fragment-Based Drug Discovery Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 12 Global Fragment-Based Drug Discovery Market, By Component, 2022 Vs 2031, %
Figure 13 Global Fragment-Based Drug Discovery Market, By Application, 2022 Vs 2031, %
Figure 14 Global Fragment-Based Drug Discovery Market, By End-User, 2022 Vs 2031, %
Figure 15 U.S. Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 16 Canada Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 17 Rest of North America Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 18 UK Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 19 Germany Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 20 Spain Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 21 Italy Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 22 France Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 23 Rest of Europe Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 24 China Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 25 Japan Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 26 India Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 27 Australia Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 28 South Korea Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 29 Rest of Asia Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 30 Brazil Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 31 Mexico Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 32 Rest of Latin America Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 33 GCC Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 34 Africa Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
Figure 35 Rest of Middle East and Africa Fragment-Based Drug Discovery Market (US$ Million), 2021 - 2031
List of Tables
Table 1 Global Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 2 Global Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 3 Global Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 4 Global Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 5 Global Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 6 North America Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 7 North America Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 8 North America Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 9 North America Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 10 North America Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 11 U.S. Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 12 U.S. Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 13 U.S. Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 14 U.S. Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 15 U.S. Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 16 Canada Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 17 Canada Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 18 Canada Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 19 Canada Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 20 Canada Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 21 Rest of North America Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 22 Rest of North America Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 23 Rest of North America Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 24 Rest of North America Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 25 Rest of North America Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 26 UK and European Union Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 27 UK and European Union Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 28 UK and European Union Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 29 UK and European Union Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 30 UK and European Union Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 31 UK Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 32 UK Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 33 UK Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 34 UK Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 35 UK Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 36 Germany Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 37 Germany Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 38 Germany Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 39 Germany Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 40 Germany Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 41 Spain Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 42 Spain Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 43 Spain Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 44 Spain Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 45 Spain Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 46 Italy Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 47 Italy Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 48 Italy Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 49 Italy Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 50 Italy Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 51 France Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 52 France Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 53 France Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 54 France Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 55 France Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 56 Rest of Europe Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 57 Rest of Europe Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 58 Rest of Europe Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 59 Rest of Europe Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 60 Rest of Europe Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 61 Asia Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 62 Asia Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 63 Asia Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 64 Asia Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 65 Asia Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 66 China Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 67 China Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 68 China Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 69 China Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 70 China Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 71 Japan Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 72 Japan Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 73 Japan Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 74 Japan Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 75 Japan Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 76 India Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 77 India Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 78 India Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 79 India Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 80 India Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 81 Australia Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 82 Australia Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 83 Australia Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 84 Australia Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 85 Australia Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 86 South Korea Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 87 South Korea Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 88 South Korea Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 89 South Korea Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 90 South Korea Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 91 Latin America Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 92 Latin America Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 93 Latin America Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 94 Latin America Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 95 Latin America Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 96 Brazil Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 97 Brazil Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 98 Brazil Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 99 Brazil Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 100 Brazil Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 101 Mexico Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 102 Mexico Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 103 Mexico Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 104 Mexico Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 105 Mexico Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 106 Rest of Latin America Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 107 Rest of Latin America Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 108 Rest of Latin America Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 109 Rest of Latin America Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 110 Rest of Latin America Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 111 Middle East and Africa Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 112 Middle East and Africa Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 113 Middle East and Africa Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 114 Middle East and Africa Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 115 Middle East and Africa Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 116 GCC Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 117 GCC Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 118 GCC Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 119 GCC Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 120 GCC Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 121 Africa Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 122 Africa Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 123 Africa Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 124 Africa Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 125 Africa Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)
Table 126 Rest of Middle East and Africa Fragment-Based Drug Discovery Market By Component, 2021-2031, USD (Million)
Table 127 Rest of Middle East and Africa Fragment-Based Drug Discovery Market By Fragment Screening, 2021-2031, USD (Million)
Table 128 Rest of Middle East and Africa Fragment-Based Drug Discovery Market By Biophysical Techniques, 2021-2031, USD (Million)
Table 129 Rest of Middle East and Africa Fragment-Based Drug Discovery Market By Application, 2021-2031, USD (Million)
Table 130 Rest of Middle East and Africa Fragment-Based Drug Discovery Market By End-User, 2021-2031, USD (Million)

Companies Mentioned

  • Pfizer Inc.
  • Novartis AG
  • Johnson & Johnson
  • Alveus Pharmaceuticals Pvt. Ltd.
  • Astex Pharmaceuticals
  • Charles River Laboratories International, Inc.
  • Beactica AB
  • Emerald BioStructures, Inc.
  • Crown Bioscience, Inc.
  • Evotec AG
  • Proteros Fragments GmbH
  • Kinetic Discovery Limited
  • Sprint Bioscience
  • Sygnature Discovery
  • Structure Based Design, Inc

Related Topics

Related Reports

Fragment-based Drug Discovery - Global Strategic Business Report - Product Image

Fragment-based Drug Discovery - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Small Molecule Drug Discovery - Global Strategic Business Report - Product Image

Small Molecule Drug Discovery - Global Strategic Business Report

  • Report
  • 376 Pages
  • Global
From
Drug Discovery Services Market - Global Forecast 2025-2032 - Product Image

Drug Discovery Services Market - Global Forecast 2025-2032

  • Report
  • 192 Pages
  • Global
From
In-Silico Drug Discovery Market - Global Forecast 2025-2032 - Product Image

In-Silico Drug Discovery Market - Global Forecast 2025-2032

  • Report
  • 181 Pages
  • Global
From
Computer-Aided Drug Discovery Market Report 2025 - Product Image

Computer-Aided Drug Discovery Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.